PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 66: Gene co-amplification and structural patterns reveal principles of extrachromosomal DNA in cancer.

View Full Paper
JLJens LuebeckTLTed LiefeldEHEdwin Huang

Key Points

  • The research aims to investigate the biology of extrachromosomal DNA (ecDNA) and its implications for tumor evolution and therapy.
  • Analyzed 6,366 whole-genome sequenced tumors from the ICGC and Hartwig Medical Foundation datasets.
  • Used the AmpliconSuite toolset for ecDNA analysis in whole genome sequencing data.
  • Conducted structural analysis to identify patterns of gene co-amplification and ecDNA assembly.
  • Identified 2,366 distinct ecDNA structures capturing over 11,000 genes.
  • Revealed that CDK4-MDM2 co-amplifications predominantly occur on ecDNA in 75% of instances.
  • Found that different cancer types exhibit unique ecDNA structure patterns, with glioblastoma showing simpler architectures compared to lung and breast cancers.

Abstract

Abstract The amplification of oncogenes on extrachromosomal DNA (ecDNA) enables aggressive, rapidly evolving tumors. Its defiance of Mendelian segregation enables extreme copy number amplifications that escape chromosomal regulatory constraints. Our AmpliconSuite toolset is the most widely used tool for ecDNA analysis in whole genome sequencing data, now deployed on over 43,000 tumor samples. Here, we present novel insights into ecDNA biology enabled through large-scale integrative analysis with these methods. We analyzed 6,366 whole-genome sequenced tumors from combined ICGC and Hartwig Medical Foundation datasets, identifying 2,366 distinct ecDNA capturing 11,000 different genes. Our systematic gene co-amplification analysis revealed striking patterns of gene selection on ecDNA. CDK4-MDM2 co-amplification occurred predominantly via ecDNA (75% of co-amplifications). These loci, normally separated by 11Mbp on chromosome 12, preferentially assembled onto the same ecDNA molecule 93% of the time as revealed by structural analysis of the ecDNA. This suggests selective pressure for maintaining cell cycle and p53 pathway regulators on the same inheritable unit. Our analysis of frequent co-amplifications also revealed that ecDNA preferentially packages chromatin remodelers (NSD3, RSF1) alongside driver oncogenes, as well as including genes that support transcription and translation (INTS4, BRF2), creating self-contained oncogene “support” hubs. Structural analysis revealed cancer type-specific patterns to ecDNA structures, with EGFR ecDNA showing simple architectures in glioblastoma versus complex rearrangements in lung and breast cancers, suggesting distinct formation histories in different cancers. Through AmpliconRepository.org, we provide public access to these ecDNA predictions and co-amplification analysis across major cancer cohorts, currently hosting 16,000+ analyzed samples and 5,000+ characterized ecDNA amplifications. Uniquely open to community contributions, this resource enables researchers to explore patterns across datasets and validate findings. These findings reveal fundamental principles governing ecDNA formation and selection, with implications for understanding tumor heterogeneity, therapeutic resistance, and dependencies which underlie ecDNA-targeted therapies. Citation Format: Jens Luebeck, Ted Liefeld, Edwin Huang, Forrest Kim, Bhargavi Dameracharla, Michael A. Chan, Dhruv Khatri, Kyra Fetter, Kaiyuan Zhu, Thorin Tabor, Soyeon Kim, Hoon Kim, Roel Verhaak, Michael M. Reich, Paul S. Mischel, Jill P. Mesirov, Vineet Bafna. Gene co-amplification and structural patterns reveal principles of extrachromosomal DNA in cancer abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 66.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Luebeck et al. (2026) studied this question.

synapsesocial.com/papers/69d1fd3da79560c99a0a3172https://doi.org/10.1158/1538-7445.am2026-66
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 3887: The origins and clinical impact of extrachromosomal DNA across 39 cancers2024
  2. 2Abstract 3526: Dynamic evolution of oncogene amplification across 80,000 cancer cell genomes2026
  3. 3Abstract 1930: Unveiling ecDNA spatial organization and epigenetic landscapes through long-read multi-omic sequencing and high-content microscopy.2026
  4. 4Abstract SY20-02: Cancer genes beyond chromosomes2026
  5. 5Extrachromosomal DNA Amplification as a Prognostic Factor for Cancer2026